Advertisement

Topics

Teva and Amgen latest to submit trastuzumab biosimilars to US FDA for review

06:52 EDT 1 Aug 2017 | BioPharma-Reporter

Original Article: Teva and Amgen latest to submit trastuzumab biosimilars to US FDA for review

NEXT ARTICLE

More From BioPortfolio on "Teva and Amgen latest to submit trastuzumab biosimilars to US FDA for review"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...